중남미 혈뇨 치료 시장 예측(2028년) – 코로나19 영향 및 치료(약물, 치료법 및 기타), 적응증(요로 감염, 신장 결석, 요도염, 혈액암, 방광 결석, 전립선암, 방광염)별 지역 분석 , 외상, 격렬한 운동, 다낭성 신장 질환, 자궁내막증 및 월경), 유형(육안적 혈뇨, 현미경적 혈뇨, 특발성 혈뇨 및 조깅하는 사람의 혈뇨), 최종 사용자(병원, 진료소, 외래 수술 센터 등)
시장 소개
혈뇨는 소변에서 혈액이 발견되는 질병입니다. . 일반적으로 소변에는 적혈구가 포함되어 있지 않으므로 신장 결석, 요로 감염 및 기타 유전 질환을 유발할 수 있는 심각한 문제를 일으킬 수 있습니다.
게다가, 유병률이 높은 혈뇨 관련 징후는 예측 기간 동안 시장 성장을 강화할 것으로 예상됩니다. 그러나 관련 적응증의 진단되지 않은 사례는 South & 중앙 아메리카 혈뇨 치료 시장.
SARS-CoV-2 전염병은 SCAM 지역의 의료에 갑작스럽고 극적인 영향을 미쳤습니다. 코로나19 팬데믹은 병원 행정에서 선택적인 사례에 대해 허용되고 일상적인 치료를 변화시켰습니다. 남미와 중미도 예외는 아닙니다. 이제 엄격한 사회적 거리두기 절차가 적용되며, 환자는 보호자 없이 개별적으로 병원에 입원하게 됩니다. CoViD-19는 거의 전 세계의 일상생활을 변화시켰습니다. 전반적으로 이러한 혼란의 규모는 팬데믹의 지역적 영향에 대한 개인의 두려움과 정부 차원의 조치로 인해 발생합니다. 그러나 문제의 급속한 전개를 알 수 없는 초기 단계에서는 지역사회의 건강을 보장하기 위해 제한 조치를 취하는 경우가 있습니다. 아르헨티나에서는 프로그램화된 의료가 마비된 상황이었다. 이러한 제한은 연구 개발 활동에 부정적인 영향을 미칠 가능성이 높으며, 이는 지역 내 혈뇨 치료 시장의 성장을 직접적으로 억제할 수 있습니다.
시장 개요 및 역학
The South & 중미 혈뇨치료제 시장은 2021년 5,780만 달러에서 2028년 6,570만 달러로 성장할 것으로 예상된다. 2021년부터 2028년까지 CAGR 1.8%로 성장할 것으로 예상됩니다. 의료 기기 및 진단 절차의 기술 발전으로 인해 신장 결석, 방광 결석 및 요로 감염과 같은 혈뇨 관련 징후를 관리하기 위한 다양한 옵션이 탄생했습니다. 첨단 치료기술을 활용해 환자 진료를 강화할 것으로 기대된다. 예를 들어, 요로결석증 치료를 위한 수술에 로봇공학을 적용하는 것은 최근 몇 년간 인기를 얻었습니다. 현재 인튜이티브 서지컬(Intuitive Surgical Inc.)의 빈치 서지컬 시스템(Vinci Surgical System)은 요로결석증 치료 수술에 널리 사용되고 있다. 마찬가지로, 신장 결석에 대한 내분비학적 중재의 활용도 여러 국가에서 크게 증가했습니다. 또한 관련 적응증의 발전이 South & 예측 기간 동안 중앙 아메리카 혈뇨 치료 시장.
주요 시장 부문
< p>유형별로는 거시적 혈뇨 부문이 남부 & 2020년 중미 혈뇨 치료 시장. 치료 측면에서 보면 의약품 부문이 South & 2020년 중미 혈뇨 치료제 시장. 적응증으로 보면 요로감염 부문이 남부 & 2020년 중미 혈뇨 치료 시장. 최종 사용자 측면에서 보면 병원 부문이 남부 & 2020년 중앙아메리카 혈뇨 치료 시장.주요 출처 및 회사 목록
< p>South & 중미에는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd 및 Boehringer Ingelheim International GmbH.구매 이유 보고서
- 남부 & 중미 혈뇨증 치료제 시장 상황 및 강력한 수익을 보장할 수 있는 시장 부문 식별
- 끊임없이 변화하는 시장 상황을 이해하고 경쟁에서 앞서 나가기 위해
- 남부 지역에서의 인수합병 및 파트너십 거래를 효율적으로 계획합니다. 가장 유망한 판매 가능성이 있는 세그먼트를 식별하여 중앙 아메리카 혈뇨 치료 시장
- 다양한 세그먼트의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식에 기반한 비즈니스 결정을 내립니다.
- 남부 및 amp; 2021~2028년 기간 동안 다양한 부문을 기반으로 하는 중앙 아메리카 혈뇨 치료 시장
SOUTH & 중앙 아메리카 혈뇨 치료 시장 세분화
기준 < span>치료
- 약물
- 치료법
- 기타
표시별
- 요로 감염
- 신장 결석
- 요도염
- 혈액암
- 방광결석
- 전립선암
- 방광염
- 외상
- 과격한 운동
- < span>다낭성 신장 질환
- 자궁내막증
- 월경
유형별
- 육안적 혈뇨
- 현미경적 혈뇨
- 특발성 혈뇨
- 조깅하는 사람의 혈뇨
최종 사용자별
- 병원 span>
- 클리닉
- 외래 수술 센터(ASC)
- 기타 span>
국가별
- 남부 & 중앙 아메리카
- 브라질
- 아르헨티나
- 남부 및 amp; 중앙 아메리카
언급된 회사
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- 머크 & 주식회사
- 노바티스 AG
- 화이자 주식회사
- < span>Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Hematuria Treatment Market – By Treatment
1.3.2 South & Central America Hematuria Treatment Market – By Indication
1.3.3 South & Central America Hematuria Treatment Market – By Type
1.3.4 South & Central America Hematuria Treatment Market – By End User
1.3.5 South & Central America Hematuria Treatment Market – By Country
2. South & Central America Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – South & Central America Analysis
6.1 South & Central America Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 South & Central America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 South & Central America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 South & Central America Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 South & Central America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. South & Central America Hematuria Treatment Market – Geographic Analysis
11.1 South and Central America: Hematuria Treatment Market
11.1.1 Overview
11.1.2 South and Central America: Hematuria Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.4 South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.5 South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.6 South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)
11.1.7.1 Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.1.1 Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.1.2 Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 Brazil: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.1.4 Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.2.1 Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.2.2 Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Argentina: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.2.4 Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.3.1 Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.3.2 Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Rest of South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.3.4 Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million
Table 4. South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Thousand)
Table 5. Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. South & Central America Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. Brazil to Show Significant Growth During Forecast Period
Figure 5. South & Central America Hematuria Treatment Market, Industry Landscape
Figure 6. South & Central America PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. South & Central America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. South & Central America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. South & Central America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. South & Central America Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. South & Central America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. South and Central America: Hematuria Treatment Market, By Key Country – Revenue (2021) (USD Million)
Figure 37. South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 38. South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)
Figure 39. Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 40. Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 41. Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 42. Impact Of COVID-19 Pandemic in South & Central America Country Markets
Figure 43. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.